Cryosite Ltd Market Cap ($42.13 Million)
Market Cap & Net Worth: Cryosite Ltd (CTE)
Cryosite Ltd market cap. Cryosite Ltd (AU:CTE) has a market capitalization of $42.13 Million (AU$59.55 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #22273 globally and #784 in its home market, demonstrating a -2.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cryosite Ltd's stock price AU$1.22 by its total outstanding shares 48809563 (48.81 Million). Also see cash efficiency ratio of Cryosite Ltd for how efficiently the company converts equity into cash flow.
Cryosite Ltd Market Cap History (2015–2026)
Cryosite Ltd market cap history from 2015 to 2026. Data shows growth from $6.50 Million to $42.13 Million (15.86% CAGR). Check today's stock price for Cryosite Ltd for real-time trading data and today's change.
Cryosite Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cryosite Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Cryosite Ltd (CTE) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.45x
Cryosite Ltd's market cap is 2.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.33x
Cryosite Ltd's market cap is 18.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.09 Million | $10.04 Million | $302.47K | 0.51x | 16.82x |
| 2017 | $3.73 Million | $5.81 Million | -$142.11K | 0.64x | N/A |
| 2018 | $1.34 Million | $5.86 Million | -$244.70K | 0.23x | N/A |
| 2019 | $1.58 Million | $7.91 Million | -$565.16K | 0.20x | N/A |
| 2020 | $11.79 Million | $8.92 Million | $1.48 Million | 1.32x | 7.97x |
| 2021 | $13.88 Million | $10.02 Million | $652.57K | 1.39x | 21.27x |
| 2022 | $22.08 Million | $11.76 Million | $1.36 Million | 1.88x | 16.19x |
| 2023 | $18.72 Million | $11.94 Million | $1.41 Million | 1.57x | 13.29x |
| 2024 | $29.36 Million | $12.61 Million | $1.84 Million | 2.33x | 15.95x |
| 2025 | $34.54 Million | $14.12 Million | $1.88 Million | 2.45x | 18.33x |
Competitor Companies of CTE by Market Capitalization
Companies near Cryosite Ltd in the global market cap rankings as of November 8, 2026. Also see CTE current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Cryosite Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $162.64 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.20 Billion USD ( CN¥363.57 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #596 globally with a market cap of $44.78 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $694.76 |
| #143 | Danaher Corporation | NYSE:DHR | $162.64 Billion | $230.25 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.20 Billion | CN¥147.00 |
| #596 | Natera Inc | NASDAQ:NTRA | $44.78 Billion | $310.67 |
Market Capitalization of Cryosite Ltd (2015–2026)
Market capitalization of Cryosite Ltd from 2015 to today. Between 2015 and today, Cryosite Ltd's market cap moved from $6.50 Million to $ 42.13 Million, with a yearly change of 15.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$42.13 Million | +22.00% |
| 2025 | AU$34.54 Million | +17.65% |
| 2024 | AU$29.36 Million | +56.80% |
| 2023 | AU$18.72 Million | -15.19% |
| 2022 | AU$22.08 Million | +59.00% |
| 2021 | AU$13.88 Million | +17.72% |
| 2020 | AU$11.79 Million | +645.63% |
| 2019 | AU$1.58 Million | +17.74% |
| 2018 | AU$1.34 Million | -64.01% |
| 2017 | AU$3.73 Million | -26.61% |
| 2016 | AU$5.09 Million | -21.73% |
| 2015 | AU$6.50 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Cryosite Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.13 Million USD |
| MoneyControl | $42.13 Million USD |
| MarketWatch | $42.13 Million USD |
| marketcap.company | $42.13 Million USD |
| Reuters | $42.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more